Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
03/2003
03/27/2003WO2003024929A1 Substituted piperidines with selective binding to histamine h3-receptor
03/27/2003WO2003024928A2 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives
03/27/2003WO2003024924A1 Novel compounds and compositions as cathepsin inhibitors
03/27/2003WO2003024922A1 Hydroxyfattysulfonic acid analogs
03/27/2003WO2003024913A1 SUBSTITUTED BENZOIC ACID DERIVATIVES EXHIBITING NF-κB INHIBITING ACTIVITY
03/27/2003WO2003024489A2 Combination of a nsaid and a pde-4 inhibitor
03/27/2003WO2003024487A1 Method of increasing the presence of glutathione in cells
03/27/2003WO2003024479A1 Enamel matrix protein compositions for modulating immune response
03/27/2003WO2003024474A2 Anti-inflammatory agent
03/27/2003WO2003024460A1 Use of 7-alpha hydroxy dhea and 7-oxo dhea for treating inflammatory or functional intestinal diseases
03/27/2003WO2003024449A1 Pharmaceutical formulations for protecting pharmaceutical compound from acidic environments
03/27/2003WO2003024446A1 Oxidation stress inhibitor and method of measuring oxidation stress
03/27/2003WO2003024439A1 Phenethanolamine derivatives for treatment of respiratory diseases
03/27/2003WO2003024402A2 Lpa receptor agonists and antagonists and methods of use
03/27/2003WO2003024395A2 Linked biaryl compounds
03/27/2003WO2003024390A2 Hydroxyeicosenoic acid analogs
03/27/2003WO2003024327A1 Magnetic resonance imaging method, apparatus, and rf reception coil apparatus
03/27/2003WO2003024237A1 Oil composition
03/27/2003WO2003002553A3 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
03/27/2003WO2002096358A3 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method
03/27/2003WO2002094263A3 Caspase inhibitors and uses thereof
03/27/2003WO2002094019A9 Highly purified antiendotoxin compound
03/27/2003WO2002090551A3 Self-containing lactococcus strain
03/27/2003WO2002083870A3 Pufa polyketide synthase systems and uses thereof
03/27/2003WO2002060859A3 Cyclic derivatives as modulators of chemokine receptor activity
03/27/2003WO2002053100A3 Pharmaceutical dosage form for oral administration of low molecular weight heparin
03/27/2003WO2002032416A3 Inhibition of emetic effect of metformin with 5-ht3 receptor antagonists
03/27/2003WO2002012340A3 Transporters and ion channels
03/27/2003WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents
03/27/2003US20030060645 Polymorphic and other crystalline forms cis-FTC
03/27/2003US20030060627 8-Phenyl-6, 9-dihydro-[1,2,4] triazolo[3,4-i]purin-5-one derivatives
03/27/2003US20030060624 Reacting 2-chloro-4- trifluoromethyl-phenyl)-acetonitrile in the presence of a palladium catalyst and a base to form indene derivative
03/27/2003US20030060506 Bile secretion promoting composition
03/27/2003US20030060497 Use of indole Mannich bases in the production of medicaments that are used to treat pain
03/27/2003US20030060492 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
03/27/2003US20030060488 Drug comprising combination
03/27/2003US20030060485 (+)-norcisapride
03/27/2003US20030060482 Urease inhibitors
03/27/2003US20030060466 Such as 6-(4-(4-Fluoro-phenyl)-piperazin-1-yl)-2-methyl-5-nitro-3-(2,2,2-trifluoro -ethyl)-3H-pyrimidin-4-one, which are metabotropic glutamate receptor antagonists useful in treating psychological disorders
03/27/2003US20030060459 Diamines as modulators of chemokine receptor activity
03/27/2003US20030060455 Treating lung damage from smoke, endometriosis, Behcet's disease, ankylosing spondylitis, cancer, Lyme disease, and/or restenosis following agioplasty with 1-(4-t-butyl-phenyl)-3-(4-(6-morpholin-4-ylmethyl-peperidin-yl)naphthalen-1 -yl)-urea
03/27/2003US20030060452 N-heterocyclic derivatives as NOS inhibitors
03/27/2003US20030060410 Use of HMG fragments as anti-inflammatory agents
03/27/2003US20030060400 A modified nucleoside comprising a purine or pyrimidine ring for treating viral infections
03/27/2003US20030059916 IRAK-4: compositions and methods of use
03/27/2003US20030059869 Novel G protein-coupled receptor, GAVE3
03/27/2003US20030059862 Antibodies against tumor necrosis factor delta (APRIL)
03/27/2003US20030059767 Zinc finger protein derivatives and methods therefor
03/27/2003US20030059458 Encapsulated carob fibers having improved product properties, process for production thereof and use thereof
03/27/2003US20030058888 Multiplex transmission system and multiplex transmitter
03/27/2003US20030057193 Method for forming a via hole, flexible wiring board using the method, and method for producing the flexible wiring board
03/27/2003CA2461073A1 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
03/27/2003CA2461072A1 Compounds which inhibit the release of inflammatory cytokines
03/27/2003CA2461071A1 Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
03/27/2003CA2460987A1 Pharmaceutical formulations for protecting pharmaceutical compound from acidic environments
03/27/2003CA2460808A1 Immune response associated proteins
03/27/2003CA2460704A1 Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies
03/27/2003CA2460578A1 Propanolamine derivative having 1,4-benzodioxane ring
03/27/2003CA2460544A1 Anti-inflammatory agent
03/27/2003CA2460460A1 Fermentation product of cryptoporus volvatus and its preparation method and use
03/27/2003CA2460358A1 Hydroxyfattysulfonic acid analogs
03/27/2003CA2460319A1 Lpa receptor agonists and antagonists and methods of use
03/27/2003CA2460263A1 Hydroxyeicosenoic acid analogs
03/27/2003CA2460125A1 Novel compounds and compositions as cathepsin inhibitors
03/27/2003CA2459773A1 Enamel matrix protein compositions for modulating immune response
03/27/2003CA2459547A1 Method of increasing the presence of glutathione in cells
03/27/2003CA2459454A1 Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists
03/27/2003CA2459140A1 Protein modification and maintenance molecules
03/27/2003CA2445513A1 Benzimidazole derivatives
03/27/2003CA2429005A1 Substituted benzoic acid derivatives having nf-kb inhibiting action
03/26/2003EP1295939A1 Insulin-like growth factor binding protein
03/26/2003EP1295603A1 The process of extracting from haw-pit by dry distillation and its device
03/26/2003EP1295538A2 Encapsulated locust bean fibre with improved properties, process for making it and use thereof
03/26/2003EP1294924A2 Method for identifying medically valuable active substances
03/26/2003EP1294905A1 Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest
03/26/2003EP1294893A2 Modification of hepatitis b core antigen
03/26/2003EP1294882A2 B7-like molecules and uses thereof
03/26/2003EP1294874A2 Cd154 variants and uses thereof
03/26/2003EP1294871A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof
03/26/2003EP1294856A1 DNAs ENCODING MAMMALIAN HISTAMINE RECEPTOR OF THE H4 SUBTYPE
03/26/2003EP1294765A2 Il-17 molecules and uses thereof
03/26/2003EP1294757A2 Glucagon-like peptide-1 analogs
03/26/2003EP1294752A2 Angiogenesis-modulating compositions and uses
03/26/2003EP1294750A2 Acid-modified arabinogalactan protein composition
03/26/2003EP1294746A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains
03/26/2003EP1294743A2 Method of obtaining peptides with tissue-specific activity and pharmaceutical compositions on their basis
03/26/2003EP1294740A2 Chemically-modified antimicrobial peptides, compositions and methods of production and use
03/26/2003EP1294735A2 Methods and compositions for treating flaviviruses and pestiviruses
03/26/2003EP1294728A1 HMG-CoA REDUCTASE INHIBITORS AND METHOD
03/26/2003EP1294724A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents
03/26/2003EP1294721A1 Cyclic gmp-specific phosphodiesterase inhibitors
03/26/2003EP1294711A2 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as as modulators of protein kinases
03/26/2003EP1294701A2 Bis-arylsulfones
03/26/2003EP1294700A2 Benzhydryl derivatives
03/26/2003EP1294699A2 Modulators of tnf- alpha signalling
03/26/2003EP1294697A1 1,2,3,5-tetrahydrobenzo[c]azepin-4-one derivatives having muscarinic antagonist activity
03/26/2003EP1294696A2 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases
03/26/2003EP1294695A2 Substituted diamide derivatives useful as motilin antagonists
03/26/2003EP1294691A1 Serine protease inhibitors
03/26/2003EP1294690A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
1 ... 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 ... 1258